Acceleron Pharma Inc. (XLRN) financial statements (2021 and earlier)

Company profile

Business Address 128 SIDNEY STREET
CAMBRIDGE, MA 02139
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments850431291277140105176
Cash and cash equivalents6712381441002128176
Short-term investments17919414717711977 
Restricted cash and investments      1
Receivables26974343
Other undisclosed current assets171084422
Total current assets:893450306285147111182
Noncurrent Assets
Operating lease, right-of-use asset2224
Property, plant and equipment8777533
Long-term investments and receivables822 969531 
Long-term investments822 969531 
Restricted cash and investments  21   
Other noncurrent assets220000 
Other undisclosed noncurrent assets    111
Total noncurrent assets:39559104101354
TOTAL ASSETS:932505315389248146186
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities53271916151311
Accounts payable8201211
Accrued liabilities4525181513127
Employee-related liabilities      3
Debt 6     
Deferred rent credit  0
Deferred revenue and credits1112
Other undisclosed current liabilities7     (3)
Total current liabilities:6033191716149
Noncurrent Liabilities
Long-term debt and lease obligation1720     
Operating lease, liability1720
Liabilities, other than long-term debt  25557
Deferred revenue and credits5557
Deferred rent credit  2
Other undisclosed noncurrent liabilities(17)21211714
Total noncurrent liabilities:17224762321
Total liabilities:77552324223730
Stockholders' equity
Stockholders' equity attributable to parent855449292365226109156
Common stock0000000
Additional paid in capital1,7331,161879839590417400
Accumulated other comprehensive income (loss)(0)0(1)(1)(0)(0) 
Accumulated deficit(877)(711)(587)(473)(364)(307)(244)
Total stockholders' equity:855449292365226109156
TOTAL LIABILITIES AND EQUITY:932505315389248146186

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues93741413281815
Revenue, net13121728
Cost of revenue      (1)
Gross profit:93741413281814
Operating expenses(260)(210)(138)(123)(94)(79)(70)
Operating loss:(167)(136)(124)(110)(66)(61)(55)
Nonoperating income (expense)112629(3)4
Investment income, nonoperating  63210
Other nonoperating income (expense)(2)1(0)(1)7(4)5
Interest and debt expense      (1)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes00(0)0(0)(0)1
Loss from continuing operations before equity method investments, income taxes:(166)(125)(119)(108)(57)(64)(51)
Other undisclosed income (loss) from continuing operations before income taxes(0)(0)0(0)0  
Loss from continuing operations before income taxes:(166)(125)(119)(108)(57)(64)(51)
Income tax expense (benefit)(0)00(0)(0)  
Net loss:(166)(125)(119)(108)(57)(64)(51)
Other undisclosed net income attributable to parent     00
Net loss available to common stockholders, diluted:(166)(125)(119)(108)(57)(64)(51)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(166)(125)(119)(108)(57)(64)(51)
Comprehensive loss:(166)(125)(119)(108)(57)(64)(51)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(0)10(0)(0)(0)0
Comprehensive loss, net of tax, attributable to parent:(166)(124)(119)(109)(57)(64)(51)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: